Abstract Details
|
Marie Beaudin, MD
PRESENTER |
Dr. Beaudin has nothing to disclose. |
| Francois Salachas (Hopital De La Pitie Salpetriere Fed Maladies) | No disclosure on file |
| Pierre-Francois Pradat, PhD (Sorbonne université) | No disclosure on file |
| Nicolas Dupre, MD, FAAN (CHU de Quebec - U Laval) | Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation. |